Genomic profiling discloses differences in imatinib-resistant gastrointestinal stromal tumors (GIST) with primary KIT exon 9 or KIT exon 11 mutations
暂无分享,去创建一个
R. Sciot | P. Rutkowski | M. Debiec‐Rychter | P. Schöffski | A. Wozniak | W. Ruka | M. Ampe | I. Wever | W. Michej | J. F. Ferreiro | L. Morzuch | Vanspauwen